Phase 3
Completed N=201
Evaluating Improvement Strategies in Addiction Treatment
Source: ClinicalTrials.gov NCT00934141 ↗Enrolled (actual)
201
Serious AEs
0.0%
Results posted
Jun 2013
Primary outcomePrimary: Change in Average Waiting Time From First Contact to Treatment — .253; 4.610; 4.723; 3.520 Change in days
Summary
Addiction treatment is often characterized by long delays between first contact and treatment as well as high no-show and drop out rates leading to unused capacity in apparently full agencies. Patients do not get needed care and agency financial stability is threatened. The Network for Improvement of Addiction Treatment (NIATx) began as a high-intensity improvement collaborative of 39 addiction treatment agencies distributed across 25 states. NIATx substantially improved time to treatment and continuation in treatment by making improvements to organizational processes (such as first contact, intake and assessment, engagement, level of care transitions, paperwork, social support, outreach, and scheduling) in preliminary studies. While the results are very encouraging, they have, by intent, been obtained from a select group of agencies using a high-cost combination of services. A more practical diffusion model is needed to spread process improvements across the spectrum of treatment agencies. This study is a cluster-randomized trial to test the effectiveness and cost of less expensive combinations of the services that make up the NIATx collaborative (interest circles, coach calls, coach visits and learning sessions).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Average Waiting Time From First Contact to Treatment |
.253; 4.610; 4.723; 3.520 | — |
| PRIMARY Change in Annual Number of Patient Admissions |
-3.6; 19.5; 0.0; 8.9 | — |
| PRIMARY Change in Average Continuation Rate Through the Fourth Treatment Session |
-.019; -.02; -.004; .013 | — |
| SECONDARY Cost of Group |
59790; 135244; 380652; 229229 | — |
Eligibility Criteria
Inclusion Criteria
- at least 60 admissions/year
- provide outpatient and intensive outpatient levels of care (as defined by ASAM)
- provide or use detox services provided by others
- have tax-exempt or government status or rely on public funding (e.g., block grants, Medicare, Medicaid, local government, private philanthropy) for at least 50% of their budget
- have adopted no more than two of the planned interventions
Exclusion Criteria
- are current NIATx members
Data sourced from ClinicalTrials.gov (NCT00934141). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.